Cytomegalovirus: is there a place for screening during pregnancy?.

Authors

  • Mariana Vide Tavares Serviço de Obstetrícia, Maternidade Dr Daniel de Matos, Hospitais da Universidade de Coimbra, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal.
  • Ana Patrícia Domingues
  • Margarida Tavares
  • Eugénia Malheiro
  • Francisco Tavares
  • Paulo Moura

DOI:

https://doi.org/10.20344/amp.1566

Abstract

The maternal and fetal/congenital infection by cytomegalovirus (CMV) during pregnancy is the leading infectious cause of neurologic impairment and hearing loss. CMV screening during pregnancy has been widely discussed for several years, but still no consensus has been established. Most developed countries do not recommend it because the majority of infected fetuses will be free of any symptom, and there is currently no reliable knowledge about fetal and neonatal prognosis and also due to lack of valid, effective and safe treatment during fetal life. The aims of this review are to discuss the physiopathology of maternal and fetal infection by CMV, the diagnosis and possible treatments, as well as to determine the usefulness of a systematic screening during pregnancy.

Downloads

Download data is not yet available.

How to Cite

1.
Vide Tavares M, Domingues AP, Tavares M, Malheiro E, Tavares F, Moura P. Cytomegalovirus: is there a place for screening during pregnancy?. Acta Med Port [Internet]. 2011 Dec. 31 [cited 2024 Dec. 12];24:1003-108. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1566

Issue

Section

Arquivo Histórico